Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

17:29 EDT 3rd September 2015 | BioPortfolio

Venture Capital News - Page: 4RSS

Read the latest Venture Capital News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Venture Capital.

Search or Follow Our Venture Capital - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Venture Capital - Page: 4 News.

Showing "venture capital" News Articles 76 to 100 of 6,900+

Tuesday 1st September 2015

GENICON, a Rand Capital Holding, Selected for 2015 Innovations of the Year Recognition

BUFFALO, N.Y., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Rand Capital Corporation (NASDAQ:RAND) ("Rand"), a business development company that makes venture capital investments in companies with emerging product, service or technology concepts, today reported that the Society of Laparoendoscopic Surgeons (SLS) has chosen GENICON, Inc. (http://geniconendo.com/), a Rand Capital portfolio company, to receive...

Till Capital Announces Board and Executive Changes

HAMILTON, Bermuda, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Till Capital Ltd. (NASDAQ:TIL) (TSX.V:TIL) (the "Company" or "Till"), a Bermuda domiciled company announces that, as a natural consequence of its increasing focus on its investment-driven reinsurance/insurance businesses, William M. Sheriff has resigned as Chairman and Chief Executive Officer ("CEO") of the Company and from all of his board and...

Pieris Pharmaceuticals Strenghtens Senior Management Team and Establishes US Headquarters in Boston

BOSTON, MA--(Marketwired - September 02, 2015) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing its proprietary Anticalin® biotherapeutic technologies, announced today a key addition to its senior leadership team with the appointment of Darlene Deptula-Hicks as Senior Vice President and Chief Financial Officer. The Company also announced the transition of its corpo...

Metso's Nomination Board to consist of representatives of Solidium, Cevian Capital, Varma and Ilmarinen

HELSINKI, Finland, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Representatives of the four largest shareholders registered in Metso's shareholder register as of September 1, 2015 are elected to the Shareholders' Nomination Board along with the Chairman of the Board of Directors as an expert member. Nomination Board is responsible for making proposals regarding the composition of the Board and the remunerat...

BIOflex Technologies Inc. Announces Appointment of Director and New CEO and Stock Option Grant

MONTREAL, QUEBEC -- (Marketwired) -- 09/02/15 -- BIOflex Technologies Inc. (TSX VENTURE: BFT) (the "Company" or "BIOflex") is pleased to announce the appointment of Mr. Michel Timperio to the board of directors. Mr. Andre Godin, Chairman stated: "We are very pleased to welcome Michel to the board of BIOflex Technologies. Michel brings a wealth of experience in sales, marketing and business and s...

Cleveland BioLabs to Present at Rodman & Renshaw 17th Annual Global Investment Conference

BUFFALO, NY -- (Marketwired) -- 09/02/15 -- Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the Rodman & Renshaw 17th Annual Global Investment Conference, September 8-10, in New York, NY. Rachel Levine, Vice President of Investor Relations for Cleveland BioLabs, will present the Company's biodefense and oncology programs on September 10 at ...

Stellar Biotechnologies Announces Reverse Stock Split Effective September 2, 2015

PORT HUENEME, CA -- (Marketwired) -- 09/02/15 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTFD) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), is pleased to announce that, effective September 2, 2015, the Company has consolidated its issued and outstanding common shares (the "Shares") on the basis of one (1) post-consol...

DiaMedica to Present at Rodman & Renshaw 17th Annual Global Healthcare Conference

MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 09/02/15 -- DiaMedica Inc. (TSX VENTURE: DMA)(OTCQB: DMCAF), today announced that the Company will be presenting at the Rodman & Renshaw 17th Annual Global Investment Conference taking place from September 8-10, 2015 at the St. Regis Hotel in New York, New York. Rick Pauls, President and CEO, is scheduled to present on Thursday, September 10th at 9...

ON DECK CAPITAL, INC. SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against On Deck Capital, Inc. -- ONDK

RADNOR, Pa., Sept. 02, 2015 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against On Deck Capital, Inc. (NYSE:ONDK) (“On Deck” or the “Company”) on behalf of purchasers of the Company’s common stock, who purchased or acquired their shares pursuant or traceable to On Deck’s Initial Public ...

MedMira Targets Technology Promotion with Latest Investment from OnSite Lab

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/02/15 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR) is entering into a CAD $5 million investment with OnSite Lab Holding AG (OnSite Lab) to increase promotion and brand building to position the Company's proprietary Rapid Vertical Flow (RVF) Technology™ as a dominant platform in the rapid diagnostics industry. "MedMira has always been about technology,...

Intellia Raises $70m To Sharpen CRISPR Scissors

Intellia Therapeutics raised a $70m Series B venture capital round that the Cambridge, Massachusetts-based company will use to sharpen its approach to CRISPR/Cas9, a pair of molecular scissors used to edit genes involved in hard-to-treat diseases.

Care Capital Properties Acquires Nine Property Portfolio with Existing Customer Senior Care Centers

Total Transaction Valued at $210 Million Care Capital Properties, Inc. (NYSE: CCP) (“CCP”) today announced that it has completed the acquisition of eight skilled nursing facilities and one assisted living facility in Shreveport, Louisiana and simultaneously entered into a long-term triple-net lease with Texas-based operator Senior Care Centers, LLC...

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2015 - 2

FOLGENDE WERTPAPIERE WERDEN AM 02.09.2015 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED EX CAPITAL ADJUSTMENT ON 02.09.2015. INSTR EXCH ISIN INSTRUMENT NAME XFRA US4528341047 IMPER...

Arkansas attorney general asks governor to set execution dates

LITTLE ROCK, Ark., Sept 1 (Reuters) - Arkansas' 10-year hiatus in capital punishment moved nearer to its end on Tuesday when state Attorney General Leslie Rutledge formally asked Governor Asa Hutchinson to set execution dates for eight inmates who ha...

Ivenix gets $42mm in Series D round

Ivenix Inc. (formerly Fluidnet; developing a smart infusion pump system) raised $42mm through its Series D round. New investor WuXi Healthcare Ventures led, and was joined by Cardinal Partners, CICA Inc., Easterly Capital, Fidelity Biosciences, and S...

BMS gets option to acquire Galecto

In its second option-based deal in as many weeks, Bristol-Myers Squibb Co. received the option to acquire Galecto Biotech AB, a 2011 Lund University and King’s College spin-off that has raised $19mm in venture funding to date.

Q&A with Quebec’s Minister of Economy, Innovation and Exports Jacques Daoust

The last three years has seen the Government of Québec take an active role in helping to revitalize Québec’s life science sector, whether it’s through backing public-private partnerships, stepping to the plate with financial commitments towards strategic venture funds, or launching programs geared towards nurturing the next generation of leading scientists and researchers. In conversation [&...

CRISPR play Intellia raises $70M

Intellia Therapeutics Inc. (Cambridge, Mass.) closed a $70 million series B round led by new investor OrbiMed. New investors including Fidelity; Janus Capital Management; Foresite Capital; Sectoral Asset Management; EcoR1 Capital; and undisclosed mut...

GTCR Completes Sale of Capella Healthcare to Medical Properties Trust

Deal Underscores Effectiveness of GTCR’s Leaders Strategy™ to Build Market-Leading Companies Through Transformational Acquisitions and Organic Growth GTCR, a leading private equity firm, today announced that it has completed the previously announced sale of its portfolio company Capella Healthcare, Inc. (“Capella” or the “Company”) to Medic...

Invion Announces Private Placement to US Institutional Investor

BRISBANE, Australia and Delaware, United States, Sept. 1, 2015 /PRNewswire/ -- Invion Limited (ASX: IVX; "Company" or "Invion"), is pleased to announce that it has entered into definitive agreements to issue the following securities to an institutional investor in the United States in a private placement for aggregate gross proceeds of approximately A$1.001 million ("Placement") by the issue of 71...

Cleveland Clinic Announces $302 Million Expansion in Florida

Cleveland Clinic announced today a $302 million expansion plan for Cleveland Clinic Florida that will include capital improvements to its campus in Weston, and a new clinic and ambulatory surgery center in Coral Springs, Fla. In Weston, the expansion will include the addition of three operating suites and additional inpatient hospital beds, as wel...

Healthcare Analytics/Medical Analytics Market by Application, Type, Delivery model, End-user - Global Forecast to 2020

LONDON, Sept. 1, 2015 /PRNewswire/ -- The healthcare analytics market is categorized on the basis of type, component, delivery model, application, end user, and region. Factors such as the rising pressure to curb healthcare costs, big data in healthcare, technological advancements, growing awareness about benefits of analytics, and increase in venture capital investments are driving market growth....

Cure Duchenne Ventures LLC Provides $1 Million to MyoTherix to Advance Promising Research to Treat Duchenne Muscular Dystrophy

CureDuchenne Ventures LLC, a company that funds research to find a cure for Duchenne muscular dystrophy, announced today that they have invested $1 million in MyoTherix Inc., a biotechnology company focused on developing novel therapeutics for the treatment of Duchenne and other muscular dystrophies. The funds will support the Company’s preclinical studi...

Mitralign Presents Percutaneous Treatment Options for Tricuspid Regurgitation Repair at ESC

European Society of Cardiology (ESC) Congress highlights need for transcatheter tricuspid valve treatment options Mitralign shared early experience with its Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) designed to treat tricuspid regurgitation (TR) in a September 1 symposium at the European Society of Cardiology (ESC) Congress i...

Tenet, Dignity Health and Ascension Form Joint Venture to Own and Operate Carondelet Health Network in Arizona

Tenet Healthcare Corporation (NYSE:THC), Dignity Health and Ascension have finalized a joint venture to own and operate Carondelet Health Network based in Tucson, Arizona. Tenet is the majority partner in the new joint venture and will manage the operations of the network’s three hospitals, two physician groups, outpatient and ambulatory services, as wel...



Advertisement
 
Advertisement
 

News Quicklinks